For use alongside antibiotics
Antibiotic resistance is potentially the biggest global threat to human healthcare in this century.
Our latest Lab4S consortium comprises the four Lab4 strains with Saccharomyces boulardii. This blend was developed and researched alongside antibiotic therapy to demonstrate its ability to reduce levels of antibiotic resistance in the re-growth microbiota.
2024
Antibiotics and Gut Microbiome Study
A double-blind, randomized, placebo-controlled study assessing the impact of probiotic supplementation on antibiotic induced changes in the gut microbiome
